ID   FHKW
AC   CVCL_6G63
SY   13W09502; Extract 226; Extract 303; Extract 431
DR   IPD-IMGT/HLA; 12644
DR   IHW; IHW09502
DR   Wikidata; Q54581781
RX   PubMed=11782282;
RX   PubMed=30844424;
WW   http://pathology.ucla.edu/workfiles/336cx.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:05; B*39:25N,50:01; C*06:02,12:03; DRB1*04:01,11:01 (IPD-IMGT/HLA=12644).
CC   HLA typing: A*02:01:01:01,02:05:01; B*39:25N,50:01:01; C*06:02:01:02,12:03:01:01; DPA1*01:03:01:03,01:03:01:02; DPB1*03:01:01(124:01),04:01:01:01(350:01); DQA1*03:03:01:01,05:05:01; DQB1*03:01:01:01,03:01:01:03; DRB1*04:01:01,11:01:01:01; DRB3*02:02:01:02; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 12
//
RX   PubMed=11782282; DOI=10.1034/j.1399-0039.2001.580411.x;
RA   Marsh S.G.E.;
RG   WHO Nomenclature Committee for Factors of the HLA System;
RT   "Nomenclature for factors of the HLA system, update June 2001.";
RL   Tissue Antigens 58:276-277(2001).
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//